Potash Corporation of Saskatchewan (NYSE: POT) and Marrone Bio Innovations (NASDAQ:MBII) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitabiliy and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Potash Corporation of Saskatchewan and Marrone Bio Innovations, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Potash Corporation of Saskatchewan 2 12 6 0 2.20
Marrone Bio Innovations 0 1 1 0 2.50

Potash Corporation of Saskatchewan currently has a consensus price target of $17.70, suggesting a potential upside of 5.46%. Marrone Bio Innovations has a consensus price target of $2.50, suggesting a potential upside of 142.72%. Given Marrone Bio Innovations’ stronger consensus rating and higher probable upside, analysts clearly believe Marrone Bio Innovations is more favorable than Potash Corporation of Saskatchewan.

Profitability

This table compares Potash Corporation of Saskatchewan and Marrone Bio Innovations’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Potash Corporation of Saskatchewan 9.41% 5.52% 2.60%
Marrone Bio Innovations -189.32% N/A -59.64%

Dividends

Potash Corporation of Saskatchewan pays an annual dividend of $0.40 per share and has a dividend yield of 2.4%. Marrone Bio Innovations does not pay a dividend. Potash Corporation of Saskatchewan pays out 81.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Volatility & Risk

Potash Corporation of Saskatchewan has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Marrone Bio Innovations has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500.

Valuation & Earnings

This table compares Potash Corporation of Saskatchewan and Marrone Bio Innovations’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Potash Corporation of Saskatchewan $3.82 billion 3.69 $1.25 billion $0.49 34.24
Marrone Bio Innovations $15.53 million 2.08 -$19.96 million N/A N/A

Potash Corporation of Saskatchewan has higher revenue and earnings than Marrone Bio Innovations.

Insider and Institutional Ownership

59.3% of Potash Corporation of Saskatchewan shares are owned by institutional investors. Comparatively, 29.5% of Marrone Bio Innovations shares are owned by institutional investors. 3.1% of Potash Corporation of Saskatchewan shares are owned by insiders. Comparatively, 7.3% of Marrone Bio Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Potash Corporation of Saskatchewan beats Marrone Bio Innovations on 10 of the 14 factors compared between the two stocks.

Potash Corporation of Saskatchewan Company Profile

Potash Corporation of Saskatchewan Inc. (PCS) is a fertilizer producer producing a range of primary crop nutrients, such as potash, nitrogen and phosphate. The Company operates through three segments: potash, nitrogen and phosphate. As of December 31, 2016, it owned and operated five potash operations in Saskatchewan and owned one in New Brunswick. Its nitrogen operations involve the production of nitrogen fertilizers and nitrogen feed and industrial products, including ammonia, urea, nitrogen solutions, ammonium nitrate and nitric acid. It has nitrogen facilities in Georgia, Louisiana, Ohio and Trinidad. Its phosphate operations include the manufacture and sale of solid and liquid phosphate fertilizers, phosphate feed and industrial acid, which is used in food products and industrial processes. It has phosphate mines and mineral processing plant complexes in Florida and North Carolina. As of December 31, 2016, the Company had four phosphate feed plants in the United States.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Receive News & Ratings for Potash Corporation of Saskatchewan Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Potash Corporation of Saskatchewan Inc. and related companies with MarketBeat.com's FREE daily email newsletter.